- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04705610
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography (EYE-SEP)
EYE-SEP : Study of Social Cognition in Patients With Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography.
This study aims to:
- analyze prospectively the prevalence of subclinical oculomotor disorders (OMDs) in different phenotypes of Multiple Sclerosis (MS) and to study correlations with brain MRI T2 data.
- highlight link between modification of visual exploration strategies to decode emotions, and social behavioral disorders, in patients with demyelinating disease, from early to clinically definite stages.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Monaco, Monaco, 98000
- Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or Female.
- 18 years old and above.
- Sufficient written and oral expression in French.
- Covered by a health insurance system
- Written informed consent signed by the patient.
For the MS group:
* Patient diagnosed according to diagnostic criteria established by Polman et al. (2010): Radiologically Isolated Syndrome compatible with MS (RIS), Clinically Isolated Syndrome compatible with MS (CIS), Relapsing-Remitting MS, Secondary Progressive MS, or Primary Progressive MS.
* Hospitalized or coming to perform a consultation.
- For the control group: No cognitive impairment (non pathological Mini-Mental State Examination (MMSE), according to age, gender and socio-cultural level).
Exclusion Criteria:
- General anaesthesia within 3 months.
- Ophthalmological problems preventing a video-oculography examination.
Oculomotor disorders:
- For the control group: "fixation disorders" or "ocular tracking disorders".
- For the MS group: atypical disorders.
- Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia.
- Other neurological or ophthalmological disorders than MS
- History of stroke.
- Psychotropic drugs consummation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy volunteer
|
|
Experimental: Radiologically Isolated Syndrome (RIS)
|
|
Experimental: Clinically Isolated Syndrome (CIS)
|
|
Experimental: Relapsing-Remitting MS (RRMS)
|
|
Experimental: Secondary Progressive MS (SPMS)
|
|
Experimental: Primary Progressive MS (PPMS)
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of Oculomotor disorders (OMD)
Time Frame: Day 0
|
To analyze prevalence of OMD in different MS phenotypes Eye movements were recorded and analyzed with an eye-tracking device during oculomotor paradigms (Fixations, horizontal and vertical reflex saccades, smooth pursuit and anti-saccades).
For each subject values were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.
|
Day 0
|
Eye gaze strategies during Emotion recognition: Affective Theory of Mind (ToM)
Time Frame: Day 0
|
Comparison of gaze patterns between control group and pathological groups, during Affective ToM task.
Evaluation criteria: number and duration of fixations.
Eye movements were recorded with an eye-tracking device.
Affective ToM was assessed using the " Reading the Mind in the Eyes " test (Baron-Cohen 2001).
|
Day 0
|
Eye gaze strategies during Emotion recognition assessment: Facial emotion recognition (FER)
Time Frame: Day 0
|
Comparison of gaze patterns between control group and pathological groups, during Facial emotion recognition tasks.
Evaluation criteria: number and duration of fixations on areas of interest.
Eye movements were recorded with an eye-tracking device.
FER was assessed using some pictures from the Ekman Faces task (1976).
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
T2 MRI lesion location: Posterior fossa lesions
Time Frame: Day 0
|
T2 MRI performed by subjects in routine care.
MRI data were described according to their nature (Posterior fossa lesions/ Brainstem-Cerebellum), and classified as present or absent.
This is used for correlation study with Oculomotor disorders.
|
Day 0
|
T2 MRI lesion location: Spinal cord lesions
Time Frame: Day 0
|
T2 MRI performed by subjects in routine care.
MRI data were described according to their nature, and classified as present or absent.
This is used for correlation study with Oculomotor disorders.
|
Day 0
|
T2 MRI lesion location: T2 lesions load
Time Frame: Day 0
|
T2 MRI performed by subjects in routine care.
MRI data were described according to their nature (>9T2), and classified as present or absent.
This is used for correlation study with Oculomotor disorders.
|
Day 0
|
Oculomotor paradigms raw performance - Horizontal saccades
Time Frame: Day 0
|
This concerns saccades Latency (in ms), Main velocity (in °/sec) and Gain (gaze accuracy) during horizontal paradigms.
Eye movements were recorded and analyzed with an eye-tracking device.
These outcome measures are used in correlation and comparison analysis.
|
Day 0
|
Oculomotor paradigms raw performance - Vertical saccades
Time Frame: Day 0
|
This concerns saccades Latency (in ms), Main velocity (in °/sec) and Gain (gaze accuracy) during vertical paradigms.
Eye movements were recorded and analyzed with an eye-tracking device.
These outcome measures are used in correlation and comparison analysis.
|
Day 0
|
Disease Disability
Time Frame: Day 0
|
Disease Disability is assessed with the Expanded Disability Status Scale (EDSS), method of quantifying disability in multiple sclerosis.
The EDSS scale ranges from 0 to 10 in 0,5-unit increments that represent higher levels of disability.
Scoring is based on an examination by a neurologist.
EDSS is used among other things for correlation study with Oculomotor disorders and oculomotor paradigms raw performance.
|
Day 0
|
Disease Duration
Time Frame: Day 0
|
Disease duration corresponds to years of evolution since initial diagnosis of the disease.
It is based on an interview with subject's neurologist, or subject's medical file.
Disease duration is used among other things for correlation study with Oculomotor disorders and oculomotor paradigms raw performance.
|
Day 0
|
Correlations between visual exploration strategies and behavioral disorders.
Time Frame: Day 0
|
To study correlations between gaze patterns and Neuropsychiatric Inventory (NPI).
Evaluation criteria: number and duration of fixations on areas of interest during social cognition task (" Reading the Mind in the Eyes " test (Baron-Cohen 2001) and Ekman Faces task).
Eye movements were recorded with an eye-tracking device.
Behavior disorders were assessed with the Neuropsychiatric Inventory.
|
Day 0
|
Correlations between visual exploration strategies and social cognition impairment: Facial emotion recognition.
Time Frame: Day 0
|
To study correlations between gaze patterns and Facial emotion recognition tasks.
Evaluation criteria: number and duration of fixations on areas of interest during Facial emotion recognition tasks (Ekman Faces task).
Eye movements were recorded with an eye-tracking device.
Facial emotion recognition impairment with the Ekman Faces task.
|
Day 0
|
Correlations between visual exploration strategies and social cognition impairment: Affective ToM.
Time Frame: Day 0
|
To study correlations between gaze patterns and Affective ToM.
Evaluation criteria: number and duration of fixations during " Reading the Mind in the Eyes " test (Baron-Cohen 2001)).
Eye movements were recorded with an eye-tracking device.
Affective ToM impairments with the " Reading the Mind in the Eyes " test (Baron-Cohen 2001).
|
Day 0
|
Correlations between Facial emotion recognition and behavioral disorders.
Time Frame: Day 0
|
To study correlations between Facial emotion recognition tasks and Neuropsychiatric Inventory (NPI).
Evaluation criteria: Ekman scores and NPI scores.
Behavior disorders were assessed with the Neuropsychiatric Inventory.
|
Day 0
|
Correlations between Emotion recognition and behavioral disorders.
Time Frame: Day 0
|
To study correlations between Affective ToM task and Neuropsychiatric Inventory (NPI).
Evaluation criteria: " Reading the Mind in the Eyes " scores (Baron-Cohen 2001).
Behavior disorders were assessed with the Neuropsychiatric Inventory.
|
Day 0
|
Correlations between Facial emotion recognition and disability level.
Time Frame: Day 0
|
To study correlations between Facial emotion recognition tasks and Expanded Disability Status Scale (EDSS).
Evaluation criteria: Ekman scores and EDSS scores.
|
Day 0
|
Correlations between Emotion recognition and disability level.
Time Frame: Day 0
|
To study correlations between Affective ToM task and Expanded Disability Status Scale (EDSS). Evaluation criteria: " Reading the Mind in the Eyes " scores (Baron-Cohen 2001). Disability level were assessed with the Expanded Disability Status Scale. |
Day 0
|
Correlations between Cognitive Theory of mind and disability level.
Time Frame: Day 0
|
To study correlations between Cognitive Theory of mind task and Expanded Disability Status Scale (EDSS).
Evaluation criteria: TOM-15 scores (TOM-15 a false-belief task to assess cognitive theory of mind).
Disability level were assessed with the Expanded Disability Status Scale.
|
Day 0
|
Correlations between Affective empathy and disability level.
Time Frame: Day 0
|
To study correlations between Affective empathy and Expanded Disability Status Scale (EDSS).
Evaluation criteria: The Empathy Quotient (EQ) scores.
Disability level were assessed with the Expanded Disability Status Scale.
|
Day 0
|
Eye gaze strategies during exploration of a specific artwork
Time Frame: Day 0
|
Comparison of gaze patterns between control group and pathological groups, during exploration of a specific artwork.
Evaluation criteria: difference in exploration strategy (chronology) on target areas.
|
Day 0
|
Collaborators and Investigators
Investigators
- Principal Investigator: Christine LEBRUN-FRENAY, PUPH, Centre de Ressources et de Compétences SEP, UMRC Pasteur 2, Université Nice Côte d'Azur, Nice-France
- Principal Investigator: Alain PESCE, PUPH, Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital (Monaco)
- Study Director: Benoit KULLMANN, MD-PHD, AREBISN (Association de Recherche Bibliographique pour les Neurosciences), Nice (France)
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EYE-SEP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Video-oculography / Social cognition tasks / Neuropsychological evaluations
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceRecruiting
-
Association de Recherche Bibliographique pour les...University of Cambridge; Centre Hospitalier Princesse Grace; Institut National...CompletedBrain Injuries | Sport Injury | Concussion, BrainMonaco
-
Hospices Civils de LyonCompletedParkinson DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAlzheimer's Disease (AD) | Lewy Body Dementia (LBD) | Frontotemporal Degeneration (FTD)France
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Trial Unit, Center for Clinical Intervention Research; Center for...CompletedPatients at Ultra-high Risk of PsychosisDenmark
-
University of CambridgeGlobal Institute for Motorsport Safety (GIMSS) - Year 1; Neurolign Technologies... and other collaboratorsCompletedConcussion, Brain | Motor Vehicle AccidentUnited Kingdom